Ph.D. Alan J. Main - 28 Feb 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
EVP, Innov & Chem Sciences
Signature
/s/ Alan J. Main, Ph.D.
Issuer symbol
LXRX
Transactions as of
28 Feb 2024
Net transactions value
-$63,949
Form type
4
Filing time
29 Feb 2024, 16:30:47 UTC
Previous filing
12 Feb 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +8,977 +4.2% 221,563 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +25,666 +12% 247,229 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +32,903 +13% 280,132 28 Feb 2024 Direct F1
transaction LXRX Common Stock Tax liability $63,949 -24,408 -8.7% $2.62 255,724 28 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -8,977 -100% 0 28 Feb 2024 Common Stock 8,977 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -25,666 -50% 25,667 28 Feb 2024 Common Stock 25,666 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -32,903 -33% 65,807 28 Feb 2024 Common Stock 32,903 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.